EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The Communicating Needs and Features of IBD Experiences (CONFIDE) Study: US and European Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Ulcerative Colitis

Simon Travis iD, Alison Potts Bleakman, Marla C Dubinsky, Stefan Schreiber, Remo Panaccione iD, Toshifumi Hibi, Theresa Hunter Gibble, Cem Kayhan, Christian Atkinson iD, Christophe Sapin, Eoin J Flynn, David T Rubin

Inflammatory Bowel Diseases · 03.06.2024 · 30 (6) · 939-949

DOI: 10.1093/ibd/izad142 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, online erschienen am 21.08.2023. Verfasst von Simon Travis und 11 weiteren Autor:innen. Beteiligte Einrichtung: Kennedy Institute and Translational Gastroenterology Unit, University of Oxford, Oxford, United Kingdom. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Health Personnel, Severity of Illness Index. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Eli Lilly and Company.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The Communicating Needs and Features of IBD Experiences (CONFIDE) study aimed to evaluate the experience and impact of ulcerative colitis (UC) symptoms on patients’ lives and elucidate gaps in communication between patients and health care professionals (HCPs).

Methods

Online, quantitative, cross-sectional surveys of patients with moderate-to-severe UC and HCPs responsible for making prescribing decisions were conducted in the United States (US) and Europe. UC disease severity was defined by treatment, steroid use, and/or hospitalization history.

Results

Surveys were completed by 200 US and 556 European patients and 200 US and 503 European HCPs. The most common UC symptoms experienced in the preceding month were diarrhea, bowel urgency, and increased stool frequency. Many patients (45.0% of US patients, 37.0% of European patients) reported wearing diapers/pads/protection at least once a week in the past 3 months due to fear/anticipation of fecal urge incontinence. The top reasons for declining participation in social events, work/school, and sports/exercise were due to bowel urgency and fear of fecal urge incontinence. HCPs ranked diarrhea, blood in stool, and increased stool frequency as the most common symptoms. While over half HCPs ranked bowel urgency as a top symptom affecting patients’ lives, less than a quarter ranked it in the top 3 most impactful on treatment decisions.

Conclusions

Similar disparities exist between patient and HCP perceptions in the United States and Europe on the experience and impact of UC symptoms. Bowel urgency has a substantial and similar impact on US and European patients, is underappreciated by HCPs, and should be addressed during routine appointments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeHealth PersonnelSeverity of Illness IndexHumansFemaleMaleCross-Sectional StudiesAdultUnited StatesEuropeMiddle AgedSurveys and QuestionnairesCommunicationPerceptionYoung AdultQuality of LifeAgedAdolescent

Stichwörter der Autor:innen

quality of lifesymptom burdenulcerative colitis

Autor:innen und Institutionen

  • Kennedy Institute and Translational Gastroenterology Unit, University of Oxford, Oxford, United Kingdom.
  • Eli Lilly and Company, Indianapolis, IN, USA.
  • Susan and Leonard Feinstein IBD Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Clinic for Internal Medicine I, University Hospital Schleswig-Holstein, Campus Kiel, Germany.
  • Inflammatory Bowel Disease Unit, Division of Gastroenterology and Hepatology, University of Calgary, Calgary, AB, Canada.
  • Center for Advanced IBD Research and Treatment, Kitasato Institute Hospital, Kitasato University, Tokyo, Japan.

ORCID-Profile: Simon Travis, Remo Panaccione, Christian Atkinson

Förderung

  • Eli Lilly and Company

Zitieren

APA

Travis, S., Potts Bleakman, A., Dubinsky, M. C., Schreiber, S., Panaccione, R., Hibi, T., Hunter Gibble, T., Kayhan, C., Atkinson, C., Sapin, C., Flynn, E. J., & Rubin, D. T. (2024). The Communicating Needs and Features of IBD Experiences (CONFIDE) Study: US and European Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Ulcerative Colitis. Inflammatory Bowel Diseases, 30(6), 939-949. https://doi.org/10.1093/ibd/izad142

Vancouver

Travis S, Potts Bleakman A, Dubinsky MC, Schreiber S, Panaccione R, Hibi T, et al. The Communicating Needs and Features of IBD Experiences (CONFIDE) Study: US and European Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Ulcerative Colitis. Inflammatory Bowel Diseases. 2024;30(6):939-949. doi:10.1093/ibd/izad142

BibTeX
@article{Travis2024,
  author = {Travis, Simon and Potts Bleakman, Alison and Dubinsky, Marla C and Schreiber, Stefan and Panaccione, Remo and Hibi, Toshifumi and Hunter Gibble, Theresa and Kayhan, Cem and Atkinson, Christian and Sapin, Christophe and Flynn, Eoin J and Rubin, David T},
  title = {The Communicating Needs and Features of IBD Experiences (CONFIDE) Study: US and European Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Ulcerative Colitis},
  journal = {Inflammatory Bowel Diseases},
  year = {2024},
  volume = {30},
  number = {6},
  pages = {939--949},
  doi = {10.1093/ibd/izad142}
}
Kostenlos starten →